Archives
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-09-01
The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid two-parameter readout for viable, apoptotic, and membrane-compromised cells in cell viability assay and cytotoxicity assay workflows. It is appropriate for endpoint apoptosis and necrosis detection by flow cytometry or fluorescence microscopy, but it should not be used alone to establish a signaling mechanism or to interpret unvalidated sample types.
-
ATRA Sensitizes Ovarian Cancer to PARP Inhibition
2026-08-31
The reference study identifies all-trans retinoic acid (ATRA) as a clinically relevant strategy for reducing cisplatin-induced resistance to PARP inhibitors in epithelial ovarian cancer. Its central mechanistic contribution is linking the resistant phenotype to an NAD+-associated signature involving ALDH1A1, NAMPT, PARP1, and CHK1, providing a rationale for sequential cisplatin, ATRA, and niraparib treatment.
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-08-31
This study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. Its knockdown enhances ZC3H12A-associated IL-6 mRNA degradation, reduces tumor-cell proliferation and migration, and weakens tumor-promoting communication involving macrophages.
-
Trypsin-Responsive Nanomedicine for Acute Pancreatitis
2026-08-30
Wang and colleagues developed a mesenchymal-stem-cell-membrane-coated mesoporous organosilica nanoparticle that targets injured pancreatic acinar cells and releases BAPTA-AM after trypsin-mediated scaffold cleavage. In a mouse model, this design reduced intracellular calcium overload, suppressed inflammatory and necrotic signaling, improved pancreatic biomarkers, and increased survival, while also illustrating how disease-specific enzymatic activation can improve precision drug delivery.
-
2'-O-Methyladenosine in Purine Assays
2026-08-29
Use 2'-O-Methyladenosine as both a defined nucleoside input for cell experiments and an analytical standard for sensitive purine metabolomics. A matrix-aware UHPLC–MS/MS workflow adds practical advantages for RNA modification nucleosides, transport studies, and nucleoside analog research.
-
JSH-23: Mechanism of an NF-κB Inhibitor
2026-08-28
JSH-23 is a small-molecule NF-κB inhibitor that blocks p65 nuclear localization and DNA binding without preventing IκB degradation. Its reported activity in LPS-stimulated macrophages and a cisplatin-induced acute kidney injury model supports its use in inflammation research and NF-κB signaling pathway study.
-
HMGCS2, LysoPC, and Pulmonary Fibrosis
2026-08-28
Yang et al. identify injured type II alveolar epithelial cells as a major source of LysoPC accumulation in bleomycin-induced pulmonary fibrosis and show that these lipids activate lung fibroblasts. The study connects epithelial HMGCS2 loss with impaired lipid degradation through the PPARα–CPT1A/CPT2 axis, offering a mechanistic framework for lipid-focused fibrosis research.
-
TNF-alpha Recombinant Murine Protein: Workflows
2026-08-27
Build reproducible apoptosis and inflammation assays with a trimeric, highly active murine cytokine and a practical dosing workflow. Pair TNF-driven receptor signaling with modern transcription-independent death assays to distinguish stimulus-specific mechanisms from general loss of viability.
-
Rotavirus Infection, Nrf2 Loss, and Redox Defense
2026-08-27
The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early stress-associated increase is followed by progressive Nrf2 depletion, nuclear loss, and suppression of antioxidant transcription. Its combination of temporal infection analysis, redox perturbation, turnover-pathway testing, and ubiquitination evidence suggests that late Nrf2 failure is not simply a consequence of oxidative stress, providing a useful framework for oxidative stress research and antiviral cell biology.
-
Malate as a Causal Probe of Mitochondrial Redox
2026-08-26
Malate is more than a tricarboxylic acid cycle intermediate: it is a controllable probe of mitochondrial redox, carbon flux, and tumor–immune signaling. This article explains how to use malate to interpret PDHA1-driven metabolic changes without confusing upstream flux effects with direct α-ketoglutarate signaling.
-
Quizartinib (AC220) Workflows for FLT3 Research
2026-08-26
Quizartinib (AC220) combines low-nanomolar FLT3 potency with selectivity that supports clean pathway-dissection experiments in AML models. This practical guide translates its biochemical, cellular, and xenograft utility into reproducible workflows while showing how recent FLT3 resistance research can inform assay design.
-
From BATF2–ATF3 to Actionable Protein Interactomes
2026-08-25
The BATF2–ATF3 axis offers a mechanistic entry point into intervertebral disc degeneration, but translational progress depends on validating the protein complexes behind the phenotype. This article outlines how magnetic co-immunoprecipitation can connect disease biology with reproducible interaction analysis, while defining controls, limitations, and strategic next steps.
-
5-Aminolevulinic acid HCl: Heme Pathway Workflows
2026-08-25
Use 5-Aminolevulinic acid HCl as a controllable entry point for studying bacterial heme metabolism, macrophage uptake, and porphyrin-associated fluorescence. This workflow translates a Salmonella virulence finding into practical dose-response, rescue, and imaging assays while clearly separating validated evidence from experimental extensions.
-
Pentoxifylline Workflows for Inflammation Research
2026-08-24
Pentoxifylline connects cAMP elevation with measurable changes in monocyte activation, ICAM-1 expression, and cytokine signaling. This guide turns the reference findings into practical cell-based workflows, mechanistic controls, translational model choices, and troubleshooting checkpoints.
-
EHEC and Danazol Models of Precocious Puberty
2026-08-24
The reference study evaluated an Eclipta prostrata–Hordeum vulgare extract complex in rat models of precocious puberty induced by Danazol or a high-fat diet. EHEC delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH expression without changing body weight, supporting further investigation of HPG-axis modulation while leaving important translational questions unresolved.